ARTICLE | Financial News
Seres Therapeutics amends IPO
June 22, 2015 7:00 AM UTC
Seres Therapeutics Inc., Cambridge, Mass. Business: Infectious, Endocrine/Metabolic, Inflammation Date announced: 2015-06-16 Type: IPO To be raised: Up to $106.3 million Shares: 6.3 million Price: $15...